Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Pneumonia

  • Article

    Steroid Dosing, Surgery Outcomes for COVID-19 Patients, and More: Highlights from 2021 Research

    July 1, 2022

    Drs. Frank and Grant did an outstanding job with their in-person In the Literature at SHM Converge. Whether to use a standard or a personalized dose of corticosteroids in hospitalized patients...

  • Article

    Administration of probiotic did not reduce ventilator-associated pneumonia in critically ill patients requiring mechanical ventilation

    January 7, 2022

    Dr. Berry Clinical question: Does administration of probiotic L rhamnosus GG to critically ill patients requiring mechanical ventilation decrease ventilator-associated pneumonia (VAP)...

  • News

    Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections

    January 29, 2021

    The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.

  • News

    Potentially practice-changing bacterial therapy trials analyzed

    October 29, 2020

    Intravenous fosfomycin could improve treatment of complicated UTIs, but adjunctive inhaled amikacin did not improve pneumonia outcomes in ventilated patients.

  • 1
    News

    FDA approves new antibiotic for HABP/VABP treatment

    June 5, 2020

    Recarbrio was previously approved by the FDA to treat patients with complicated urinary tract infections and complicated intra-abdominal infections.

  • News

    FLU/SAL inhalers for COPD carry greater pneumonia risk

    June 4, 2020

    Pneumonia risks from different types of inhaled corticosteroids have not been well understood.

  • 1
    News

    CDC: Five confirmed 2019-nCoV cases in the U.S.

    January 27, 2020

    At this time in the United States, the virus is not spreading in the community.

  • 1
    Opinion

    Guideline: Diagnosis and treatment of adults with community-acquired pneumonia

    November 22, 2019

    The practice guideline was jointly written by an ad hoc committee of the American Thoracic Society and Infectious Diseases Society of America.

  • 1
    News

    In-hospital flu shot reduced readmissions in pneumonia patients

    October 22, 2019

    NEW ORLEANS – In-hospital influenza vaccination linked to lower readmission rates in database analysis.

  • News

    Lefamulin found noninferior to moxifloxacin for bacterial pneumonia

    October 1, 2019

    Oral lefamulin, the first pleuromutilin antibiotic approved for intravenous and oral administration, was noninferior to oral moxifloxacin for inducing an early clinical response in patients with bacterial pneumonia, acording to data from a global multicenter study of 738 individuals.

1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences